Hotchkis & Wiley Capital Management LLC lowered its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 8.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 308,230 shares of the industrial products company's stock after selling 28,200 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned about 0.76% of TriMas worth $7,869,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of TRS. Innealta Capital LLC purchased a new stake in shares of TriMas during the 2nd quarter valued at $26,000. Aristides Capital LLC acquired a new position in TriMas in the second quarter valued at $245,000. Intech Investment Management LLC purchased a new stake in TriMas during the third quarter valued at about $269,000. Paloma Partners Management Co acquired a new stake in TriMas during the third quarter worth about $293,000. Finally, Algert Global LLC raised its holdings in shares of TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company's stock worth $403,000 after purchasing an additional 639 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.
TriMas Stock Down 1.0 %
Shares of NASDAQ TRS traded down $0.26 on Thursday, hitting $26.33. The company had a trading volume of 192,064 shares, compared to its average volume of 266,362. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. TriMas Co. has a 12-month low of $22.45 and a 12-month high of $28.51. The firm has a market capitalization of $1.07 billion, a P/E ratio of 41.14 and a beta of 0.66. The business has a 50 day moving average of $26.53 and a two-hundred day moving average of $25.83.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). The company had revenue of $229.36 million during the quarter, compared to analysts' expectations of $239.33 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm's revenue was down 2.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.57 EPS. As a group, equities research analysts forecast that TriMas Co. will post 1.69 earnings per share for the current fiscal year.
TriMas Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend was Tuesday, November 5th. TriMas's dividend payout ratio (DPR) is 25.00%.
Analyst Ratings Changes
A number of analysts recently issued reports on the stock. StockNews.com raised shares of TriMas from a "sell" rating to a "hold" rating in a research report on Wednesday, November 13th. BWS Financial reissued a "buy" rating and issued a $40.00 target price on shares of TriMas in a research note on Tuesday, November 5th.
Get Our Latest Research Report on TRS
TriMas Company Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
